Know Cancer

forgot password

RSSearch Registry-Long Term Study of Use of SRS/SBRT to Treat Tumors and Other Functional Diseases

Open (Enrolling by invite only)
Benign Tumors, Malignant Tumors, CNS Tumors, Arteriovenous Malformation of Central Nervous System, Trigeminal Neuralgia, Breast Cancers, Gynecologic Cancers, Lung Neoplasms, Liver Neoplasms, Pancreatic Cancer, Prostatic Neoplasms

Thank you

Trial Information

RSSearch Registry-Long Term Study of Use of SRS/SBRT to Treat Tumors and Other Functional Diseases

The Registry is designed to help SRS/SBRT users to understand utilization of and key
treatment outcomes for these treatment approaches. Some of the objectives include:

Allow participants to record information about usage of SRS/SBRT in everyday practice,
including patient characteristics and disease information, treatment plans and outcomes
Provide participants with ready access to data for publication of their own experience and
as a tool for establishing collaborations with other participating sites Facilitate quality
improvement efforts for individual treatment providers Understand the effectiveness of
different treatment plans for different types of lesions, diseases and treatments

The Registry tracks select outcomes for each condition treated by SRS/SBRT (for example, PSA
for prostate cancer); the Registry also provides individual participants the ability to add
additional outcomes for each and any condition of specific interest to their institutions.

The Registry is hosted by Advertek, Inc who is an independent vendor of electronic
registries; they are responsible for HIPAA compliance, including all security mechanisms.

Patients will be enrolled prospectively. Some retrospective patient data is likely to be
included in order to capture both short and longer term outcomes data.

Inclusion Criteria:

- Diagnosis of benign or malignant tumors or other conditions deemed treatable by
stereotactic radiosurgery or stereotactic body radiotherapy

- Willingness to sign an Informed Consent Document

Exclusion Criteria:

- There are no specific exclusion criteria, but patients who are unwilling to sign the
ICD will not be included

Type of Study:

Observational [Patient Registry]

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Overall survival

Outcome Time Frame:

Up to 5 years

Safety Issue:


Principal Investigator

Clinton Medbery, MD

Investigator Role:

Study Director

Investigator Affiliation:

The Radiosurgery Society


United States: Institutional Review Board

Study ID:




Start Date:

March 2012

Completion Date:

December 2025

Related Keywords:

  • Benign Tumors
  • Malignant Tumors
  • CNS Tumors
  • Arteriovenous Malformation of Central Nervous System
  • Trigeminal Neuralgia
  • Breast Cancers
  • Gynecologic Cancers
  • Lung Neoplasms
  • Liver Neoplasms
  • Pancreatic Cancer
  • Prostatic Neoplasms
  • Congenital Abnormalities
  • Arteriovenous Malformations
  • Aneurysm
  • Hemangioma
  • Neoplasms
  • Neuralgia
  • Trigeminal Neuralgia
  • Vascular Malformations
  • Cardiovascular Abnormalities
  • Cardiovascular Diseases
  • Vascular Diseases
  • Neoplasms, Vascular Tissue
  • Neoplasms by Histologic Type
  • Pain
  • Neurologic Manifestations
  • Nervous System Diseases
  • Peripheral Nervous System Diseases
  • Neuromuscular Diseases
  • Signs and Symptoms
  • Trigeminal Nerve Diseases
  • Cranial Nerve Diseases
  • Congenital Abnormalities
  • Arteriovenous Malformations
  • Aneurysm
  • Hemangioma
  • Breast Neoplasms
  • Neoplasms
  • Liver Neoplasms
  • Lung Neoplasms
  • Neuralgia
  • Pancreatic Neoplasms
  • Prostatic Neoplasms
  • Trigeminal Neuralgia
  • Central Nervous System Neoplasms